
UK competition regulators have dropped their probe into the IAG-Air Europa merger, after the two sides terminated the tie-up in the form originally envisioned.
IAG had proposed to acquire the whole of Spanish carrier Air Europa’s share capital from parent Globalia, an agreement which was subsequently amended a number of times last year.
The UK Competition and Markets Authority had opened an inquiry in mid-November 2021, inviting comments on whether the merger would reduce competition in the UK sector.
But within a month IAG and Globalia opted to abandon the original agreement and its subsequent revisions in full, and this has prompted the UK authority to halt its investigation.
“Accordingly, on the basis of the information available to it, the [Competition and Markets Authority] does not believe that it is, or may be, the case that arrangements are in progress or in contemplation which, if carried into effect, will result in the creation of a relevant merger situation,” it stated.
While the authority would have had to decide whether to submit the deal to a more in-depth investigation by January 19, it stated that, as a result of the situation, it “does not…have a duty” to refer the merger under UK enterprise legislation.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas